Liver cancer: the cirrhosis connection, the surveillance that catches it early, and the treatments by stage
Last updated September 3, 2026.
Liver cancer, most often hepatocellular carcinoma, usually grows in a liver already injured by cirrhosis, from hepatitis B or C, alcohol, fatty liver disease, or the other chronic injuries. That is why the people at risk are offered ultrasound surveillance every six months: in a watched liver, the cancer is often caught small, at the stage where the curative options live. The treatment is chosen by stage and by how the underlying liver is coping: surgery to remove the tumor where the liver has reserve, ablation that burns or freezes small tumors, liver transplantation for the right candidates, which treats the cancer and the cirrhosis together, and, for the later stages, the medicines that slow it, the targeted drugs and immunotherapies that have improved the advanced outlook. The honest picture: found early in a surveillance program, this is a cancer with real curative routes; found late with symptoms, it is harder, and even then the modern treatments give time and options. The worth-knowing part: treating the underlying cause, curing hepatitis C, stopping alcohol, managing the fatty liver, both prevents the cancer and strengthens the liver that has to carry the treatment.
What does it look like?
Early: usually nothing at all, which is the whole argument for the six-monthly scans in anyone with cirrhosis. Later: pain or discomfort in the right upper abdomen, a swelling there, weight loss, appetite loss, worsening fatigue, yellowing skin or eyes, itchy skin, a swelling abdomen, or a sudden worsening of a cirrhosis that had been stable.
Why does it happen?
The liver cells divide for years in an inflamed, scarred organ, and the accumulated damage eventually lets one escape the controls. The causes of the cirrhosis are the causes of the cancer: hepatitis B and C, alcohol, fatty liver disease tied to weight and diabetes, and the rarer inherited liver conditions. Some cases arise without cirrhosis, especially with hepatitis B, but the center of gravity is the injured liver.
How is it treated?
- Early cancers have curative routes. Resection removes the tumor where the liver has the reserve to cope, ablation destroys small tumors in place, and transplantation, for patients within the accepted criteria, removes the cancer and the cirrhosis in one operation.
- Local treatments hold the middle ground. Treatments delivered into the liver's blood supply, blocking the tumor's feeding vessels or carrying chemotherapy or radiation to them, control cancers that cannot be removed and can bridge patients to transplant.
- The medicines have changed the advanced stage. Immunotherapy combinations and the targeted drugs now give people with advanced disease time measured in years for some, and the options continue to widen.
- The underlying liver gets treated in parallel. Curing hepatitis C, antiviral control of hepatitis B, stopping alcohol completely, and managing weight and diabetes all protect the liver that has to carry everything else.
When does it need urgent review?
In someone with cirrhosis: sudden worsening, a rapidly swelling abdomen, vomiting blood, black stools, new confusion or sleepiness, or jaundice deepening quickly is a same-day assessment, whatever the scan schedule says. Pymander's escalation routing is built and tested specifically for this class of decision; see the safety architecture working paper.
What a Pymander AI doctor consult looks like
Illustrative example, not a real member's messages.
Common questions
Is surveillance supposed to find it like this? I almost feel tricked.
Yes, this is exactly the system working as designed, and the tricked feeling is worth examining. The six-monthly scans exist because liver cancer grows from small to serious on a clock the interval is built to beat: found at 2.8cm, your tumor is at the stage where the curative options, ablation, resection, transplant assessment, are all open. The program did not fail you by finding something; finding something small is its one job. The disbelief comes from a reasonable place: years of normal scans train you to expect normal, and the abnormal one feels like a breach. Reframe it: every normal scan was the system confirming safety, and this one is the system catching the thing early, which is the outcome the whole program was built to produce.
Am I allowed to believe the word curable?
At this stage, in your situation, yes: curable is the accurate word, not a kindness. A small tumor found by surveillance, in a liver with four years of stability after the hepatitis C cure, is precisely the scenario where ablation, resection, and transplantation cure people, and the team used the word twice because it belongs in the room. The honest edges: the final plan waits on full staging, the liver's function matters as much as the tumor's size for which option fits, and surveillance continues afterward because a cirrhotic liver can grow another tumor, caught the same way. None of that softens the central fact: this is the version of a liver cancer diagnosis where cure is the plan, not the hope.
Why do I need a transplant assessment if the tumor is small?
Because for the right candidates, transplantation is the option that treats two diseases at once: it removes the cancer and it removes the cirrhotic liver that grew it, which no other treatment does. The assessment is not a sign that things are worse than you were told; it is the team checking whether you fit the accepted criteria, small tumor, no spread, liver sick enough to justify it, body strong enough to carry it. Some patients in your position are best served by ablation or resection and keep their own liver; others by transplant. The assessment is how the team finds out which column you are in, and being assessed costs nothing but appointments.
My hepatitis C was cured. Why did I still get this?
Because curing the virus stops the damage; it does not un-scar the liver. The cirrhosis that built up over the years before the cure is the soil the cancer grew from, and that risk falls substantially after cure but does not fall to zero, which is exactly why the surveillance program kept scanning you after the virus was gone. The unfairness of it is real and worth naming: you did the hard thing, got cured, and the old damage still presented its bill. The counterweight is that the cure mattered enormously: your liver now is stronger than it would have been, your options are wider, and the cancer was caught at 2.8cm rather than found by symptoms. The cure did not prevent this; it made this survivable.
What happens after treatment? Is it just over?
The tumor gets treated, and then the relationship with the liver team continues, for a sensible reason: a cirrhotic liver can grow another tumor, so the surveillance scans continue after treatment, on the same logic that caught this one, and a second tumor caught early is treated the same way. The transplant route, if you take it, exchanges that surveillance for the transplant follow-up instead. The liver health work runs in parallel whatever happens: the hepatitis C stays cured, alcohol stays at zero, and the weight, diabetes, and fatty-liver factors stay managed, because the liver that carries the future deserves the same protection as the one that carried the treatment. It is not just over; it becomes a watched, managed ordinary life.
Could this have been found sooner, or prevented?
Found sooner, no: the surveillance interval is built around the cancer's growth speed, and 2.8cm on schedule is the system landing on time, not late. Prevented, mostly no: the seeds were laid in the years of hepatitis C before your cure, and curing the virus was the prevention that was available, which you did. The remaining levers after cure are the liver-health ones, alcohol at zero, weight and diabetes managed, and those matter going forward for the liver you keep. The honest summary: this was caught at the earliest practical moment in a person who did the right things, and the right things are why the word curable is in the room.